Literature DB >> 10818071

Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries.

R Alzamora1, L Michea, E T Marusic.   

Abstract

The aim of the present study was to demonstrate rapid effects of aldosterone on the Na(+)-H(+) exchanger in strips of human vascular vessels and to determine whether 11beta-hydroxysteroid dehydrogenase enzyme (11beta-HSD) could play a protective role in this response, such as that described for the classic type I mineralocorticoid receptor (MR). The activity of 11beta-HSD isoforms 1 and 2 were measured in fetal and adult arteries. Both isoforms are present in adult and fetal vessels. However, a significant difference in the proportion of each isoform was found. Isoform 1 activity (in pmol x min(-1) x 100 mg(-1) protein) was 42+/-5 in fetal vessels and 29+/-2 in adult arteries, and isoform 2 activity was 78+/-7 in fetal and 12+/-2 in adult tissue. The nongenomic effect of aldosterone on Na(+)-H(+) exchanger activity was measured in strips of chorionic and radial uterine arteries loaded with the pH-sensitive dye 2',7'-bis(2-carboxyethyl)-5,6-carboxyfluorescein. Recordings of intracellular pH (pH(i)) were made by videofluorescence microscopy. Aldosterone (0.5 nmol/L) rapidly increased pH(i), with a half-maximal effect between 2 and 3 nmol/L in both fetal and adult vessels. Ethylisopropylamiloride, a specific inhibitor of the Na(+)-H(+) exchanger, inhibited this effect. The hormone-mediated increase in pH(i) was unaffected by spironolactone, a classic antagonist of MR, but was completely blocked by RU28318. Cortisol (up to 1 micromol/L) had no effect on pH(i), but when applied in the presence of carbenoxolone, a dramatic increase in Na(+)-H(+) exchanger activity was evident. The increments on pH(i) for each cortisol concentration were similar to those observed for aldosterone. These findings suggest that vascular 11beta-HSD plays an active role in maintaining the specificity of the rapid effects of aldosterone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818071     DOI: 10.1161/01.hyp.35.5.1099

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  21 in total

1.  Interaction between the C(-344)T polymorphism of CYP11B2 and alcohol consumption on the risk of essential hypertension in a Chinese Mongolian population.

Authors:  Xing-Qiang Pan; Yong-Hong Zhang; Yong-Yue Liu; Wei-Jun Tong
Journal:  Eur J Epidemiol       Date:  2010-09-29       Impact factor: 8.082

Review 2.  30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature.

Authors:  Jennifer J DuPont; Iris Z Jaffe
Journal:  J Endocrinol       Date:  2017-07       Impact factor: 4.286

Review 3.  Effects of aldosterone and mineralocorticoid receptor blockade on intracellular electrolytes.

Authors:  Martin Wehling
Journal:  Heart Fail Rev       Date:  2005-01       Impact factor: 4.214

Review 4.  Mineralocorticoid receptors in vascular function and disease.

Authors:  Amy McCurley; Iris Z Jaffe
Journal:  Mol Cell Endocrinol       Date:  2011-06-24       Impact factor: 4.102

5.  Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways.

Authors:  Brenna G Newfell; Lakshmanan K Iyer; Najwa N Mohammad; Adam P McGraw; Afshin Ehsan; Giuseppe Rosano; Paul L Huang; Michael E Mendelsohn; Iris Z Jaffe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05-26       Impact factor: 8.311

Review 6.  Nongenomic actions of adrenal steroids in the central nervous system.

Authors:  N K Evanson; J P Herman; R R Sakai; E G Krause
Journal:  J Neuroendocrinol       Date:  2010-03-27       Impact factor: 3.627

Review 7.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 8.  Aldosterone: a risk factor for vascular disease.

Authors:  Mario Fritsch Neves; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

Review 9.  Genomic and rapid effects of aldosterone: what we know and do not know thus far.

Authors:  Milla Marques Hermidorff; Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

Review 10.  Nuclear envelope: nanoarray responsive to aldosterone.

Authors:  H Oberleithner
Journal:  J Membr Biol       Date:  2004-06-01       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.